Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Saved in:
| Title: | Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. |
|---|---|
| Authors: | Benitez-Ribas D; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Flórez-Grau G; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Molero MC; Department of Clinical Trials, Hospital Sant Joan de Déu, Barcelona, Spain., Puerta P; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Guillen A; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Paco S; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Carcaboso AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Santa-Maria Lopez V; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., de Torres C; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Salvador N; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Juan M; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.; Department of Immunotherapy, Hospital Sant Joan de Déu, Barcelona, Spain., Mora J; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., La Madrid AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain. |
| Source: | Frontiers in oncology [Front Oncol] 2018 Apr 26; Vol. 8, pp. 127. Date of Electronic Publication: 2018 Apr 26 (Print Publication: 2018). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2018.00127 |
